These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22434791)

  • 21. Immunocytochemical staining of fine-needle aspiration biopsies of the liver as a diagnostic tool for hepatocellular carcinoma.
    Johnson DE; Powers CN; Rupp G; Frable WJ
    Mod Pathol; 1992 Mar; 5(2):117-23. PubMed ID: 1374187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study.
    Zhang L; Liu H; Sun L; Li N; Ding H; Zheng J
    Acta Histochem; 2012 Oct; 114(6):547-52. PubMed ID: 22119409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
    Somorácz A; Tátrai P; Horváth G; Kiss A; Kupcsulik P; Kovalszky I; Schaff Z
    Hum Pathol; 2010 Sep; 41(9):1310-9. PubMed ID: 20471664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
    Osada M; Aishima S; Hirahashi M; Takizawa N; Takahashi S; Nakamura K; Tanaka M; Maehara Y; Takayanagi R; Oda Y
    Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel.
    Saleh HA; Aulicino M; Zaidi SY; Khan AZ; Masood S
    Diagn Cytopathol; 2009 Mar; 37(3):184-90. PubMed ID: 19170172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy.
    Anatelli F; Chuang ST; Yang XJ; Wang HL
    Am J Clin Pathol; 2008 Aug; 130(2):219-23. PubMed ID: 18628090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology.
    Saad RS; Luckasevic TM; Noga CM; Johnson DR; Silverman JF; Liu YL
    Diagn Cytopathol; 2004 Jan; 30(1):1-6. PubMed ID: 14696137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocyte paraffin 1 and arginase-1 are effective panel of markers in HBV-related HCC diagnosis in fine-needle aspiration specimens.
    Moudi B; Mahmoudzadeh-Sagheb H; Heidari Z
    BMC Res Notes; 2020 Aug; 13(1):388. PubMed ID: 32854754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
    Patsenker E; Wilkens L; Banz V; Osterreicher CH; Weimann R; Eisele S; Keogh A; Stroka D; Zimmermann A; Stickel F
    J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of thyroid transcription factor-1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma.
    Wieczorek TJ; Pinkus JL; Glickman JN; Pinkus GS
    Am J Clin Pathol; 2002 Dec; 118(6):911-21. PubMed ID: 12472285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alanine-glyoxylate aminotransferase 1 (AGXT1) is a novel marker for hepatocellular carcinomas.
    Zhao CL; Hui Y; Wang LJ; Yang D; Yakirevich E; Mangray S; Huang CK; Lu S
    Hum Pathol; 2018 Oct; 80():76-81. PubMed ID: 29883780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver.
    Ahuja A; Gupta N; Kalra N; Srinivasan R; Chawla Y; Rajwanshi A
    Cytopathology; 2008 Aug; 19(4):229-35. PubMed ID: 18070122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase.
    Seimiya M; Tomonaga T; Matsushita K; Sunaga M; Oh-Ishi M; Kodera Y; Maeda T; Takano S; Togawa A; Yoshitomi H; Otsuka M; Yamamoto M; Nakano M; Miyazaki M; Nomura F
    Hepatology; 2008 Aug; 48(2):519-30. PubMed ID: 18571811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MOC-31 aids in the differentiation of metastatic adenocarcinoma from hepatocellular carcinoma.
    Niemann TH; Hughes JH; De Young BR
    Cancer; 1999 Oct; 87(5):295-8. PubMed ID: 10536355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of glypican-3 immunocytochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver utilizing fine needle aspiration cytology.
    Zaakook M; Ayoub M; Sinna EA; El-Sheikh S
    J Egypt Natl Canc Inst; 2013 Dec; 25(4):173-80. PubMed ID: 24207089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
    Geramizadeh B; Boub R; Rahsaz M
    Indian J Pathol Microbiol; 2007 Jul; 50(3):507-10. PubMed ID: 17883119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The utility of SMAD4 as a diagnostic immunohistochemical marker for pancreatic adenocarcinoma, and its expression in other solid tumors.
    Ali S; Cohen C; Little JV; Sequeira JH; Mosunjac MB; Siddiqui MT
    Diagn Cytopathol; 2007 Oct; 35(10):644-8. PubMed ID: 17854080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative.
    Clark I; Shah SS; Moreira R; Graham RP; Wu TT; Torbenson MS; Chandan V
    Hum Pathol; 2017 Nov; 69():90-95. PubMed ID: 28970136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms:  A Potential Diagnostic Pitfall.
    Askan G; Deshpande V; Klimstra DS; Adsay V; Sigel C; Shia J; Basturk O
    Am J Clin Pathol; 2016 Aug; 146(2):163-9. PubMed ID: 27425386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.